NCT05049057View on ClinicalTrials.gov

Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI

PHASE2RecruitingINTERVENTIONAL
Enrollment

404

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

May 19, 2026

Study Completion Date

May 19, 2027

Conditions
Posttraumatic HeadacheMild Traumatic Brain Injury
Interventions
DRUG

Erenumab 140 Mg/mL Subcutaneous Solution

Active erenumab delivered via subcutaneous injection.

DRUG

Placebo

Placebo delivered via subcutaneous injection.

Trial Locations (4)

15203

NOT_YET_RECRUITING

University of Pittsburgh Concussion Research Laboratory, Pittsburgh

28310

RECRUITING

Womack Army Medical Center - Fort Liberty, Fort Bragg

79918

RECRUITING

William Beaumont Army Medical Center, El Paso

98431

NOT_YET_RECRUITING

Madigan Army Medical Center, Tacoma

All Listed Sponsors
lead

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER